Nurix Therapeutics Inc (NRIX)

Date: O: H: L: C: Vol:

Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-08-31	2026-05-31	2026-02-28	2025-11-30	2025-08-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7,343%673.06	9.04	6.25	13.58	7.89
	10.04%113.61	103.25	98.75	96.67	99.28
Research and Development	9.58%79.26	87.65	84.14	83.02	86.12
Depreciation and Amortization	5.14%2.14	2.26	2.20	2.12	2.03
Operating Income/Loss	693.87%559.45	-94.20	-92.50	-83.10	-91.39
Income/Loss From Continuing Operations Before Tax	727.37%563.41	-89.81	-	-78.22	-86.42
Income Tax Expense/Benefit	5,121%13.61	-0.27	-	-	-
	714.07%549.81	-89.54	-87.17	-78.22	-86.42
Attributable To Parent	714.07%549.81	-89.54	-87.17	-78.22	-86.42
Basic Average Shares	0.43%111.56	111.08	110.07	2.80	84.16
Diluted Average Shares	4.56%116.15	111.08	110.07	2.80	84.16
Basic Earnings Per Share	708.64%4.93	-0.81	-0.79	-0.83	-1.03
Diluted Earnings Per Share	683.95%4.73	-0.81	-0.79	-0.83	-1.03
Common Stock Dividends	-	-	-	-	-